Clinical trial
Intravenous Administration of Microplasmin for Treatment of Acute Ischemic…
NCT00123305 · ThromboGenics, Industry · Completed
Key facts
| NCT number | NCT00123305 |
|---|---|
| Title | Intravenous Administration of Microplasmin for Treatment of Acute Ischemic Stroke |
| Official title | A Multicentre, Double-Blind, Placebo-Controlled, Ascending-dose, Clinical Trial of Intravenous Microplasmin Administration in Patients With Acute Ischemic Stroke |
| Lead sponsor | ThromboGenics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stroke, Acute |
| Intervention type | Drug |
| Interventions | Microplasmin |
| Enrollment | 40 |
| Start date | Oct 1, 2005 |
| Primary completion | May 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Jul 22, 2005 |
| Last update posted | Nov 7, 2014 |
| Countries | Austria, Belgium, Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: